发明授权
US07192971B2 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
失效
4-杂芳基四氢喹啉及其作为胆固醇酯转移蛋白的抑制剂的用途
- 专利标题: 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
- 专利标题(中): 4-杂芳基四氢喹啉及其作为胆固醇酯转移蛋白的抑制剂的用途
-
申请号: US11257931申请日: 2005-10-25
-
公开(公告)号: US07192971B2公开(公告)日: 2007-03-20
- 发明人: Jürgen Stoltefuss , Michael Lörges , Gunter Schmidt , Arndt Brandes , Carsten Schmeck , Klaus-Dieter Bremm , Hilmar Bischoff , Delf Schmidt
- 申请人: Jürgen Stoltefuss , Michael Lörges , Gunter Schmidt , Arndt Brandes , Carsten Schmeck , Klaus-Dieter Bremm , Hilmar Bischoff , Delf Schmidt
- 申请人地址: DE Leverkusen
- 专利权人: Bayer Aktiengesellschaft
- 当前专利权人: Bayer Aktiengesellschaft
- 当前专利权人地址: DE Leverkusen
- 代理机构: Norris McLaughlin & Marcus PA
- 优先权: DE19741051 19970918
- 主分类号: A61K31/4709
- IPC分类号: A61K31/4709 ; C07D401/04
摘要:
Hetero-tetrahydroquinolines can be prepared either by condensing correspondingly substituted hetero-tetrahydroquinoline aldehydes with the desired substituent or by reducing the corresponding keto-substituted hetero-tetrahydroquinolines, followed by introduction of the desired substituent by customary methods. The hetero-tetrahydroquinolines are suitable for use as active compounds in medicaments, in particular in medicaments for treating artheriosclerosis and dyslipidaemias.
公开/授权文献
信息查询
IPC分类: